e-learning
resources
Vienna 2009
Monday, 14.09.2009
New treatment and outcome measures for pulmonary rehabilitation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Different effects of pulmonary rehabilitation in patients with COPD and α-1-deficiency emphysema (AAT)
K. Kenn, S. Baumeister, M. Boensch, B. Sczepanski, C. Vogelmeier (Schoenau am Koenigssee, Marburg, Germany)
Source:
Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation
Session:
New treatment and outcome measures for pulmonary rehabilitation
Session type:
E-Communication Session
Number:
1714
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Kenn, S. Baumeister, M. Boensch, B. Sczepanski, C. Vogelmeier (Schoenau am Koenigssee, Marburg, Germany). Different effects of pulmonary rehabilitation in patients with COPD and α-1-deficiency emphysema (AAT). Eur Respir J 2009; 34: Suppl. 53, 1714
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Effects of pulmonary rehabilitation in patients with interstitial lung disease (ILD)
Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation
Year: 2009
Are there differences in response to pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) and COPD patients?
Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017
Clinical application of the COPD assessment test (CAT) in patients with idiopathic pulmonary fibrosis
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017
Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013
Estimating the effectiveness of pulmonary rehabilitation for different severity of COPD, ILD and IPF
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020
Pulmonary rehabilitation (PR) outcomes in chronic obstructive pulmonary disease (COPD) compared with interstitial lung disease (ILD)
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011
Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018
Measurement of improved activities after pulmonary rehabilitation (PR) in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 223s
Year: 2001
The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008
Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
Validation of CAT as an independent assessment tool in pulmonary rehabilitation (PR) for chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - The best posters on quality of life and coping styles in COPD
Year: 2012
Effects of pulmonary rehabilitation on systemic and pulmonary inflammation in COPD patients
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010
An evaluation of the validity of two measurements of dyspnoea as outcomes of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 182s
Year: 2002
The experiences and expectations of patients with chronic obstructive pulmonary disease (COPD) referred to pulmonary rehabilitation in the UK
Source: Annual Congress 2010 - Exercise training: new groups, new methods and outcomes
Year: 2010
Comparison of CT scan-measured pulmonary artery to aorta ratio of combined pulmonary fibrosis and emphysema (CPFE) and COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Effect of metformin on clinically relevant outcomes in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Effects of pulmonary rehabilitation on operational chest wall volumes during exercise in COPD patients
Source: Annual Congress 2006 - Physiological responses to rehabilitation
Year: 2006
Effects of pulmonary rehabilitation in asthma patients
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017
Effects of pulmonary rehabilitation in patients with asthma
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018
Influence of bronchodilators on pulmonary hypertension (PH) in patients with moderate and severe chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept